Civic group seeking further price reduction of new drug

Following the recent insurance price reduction of AstraZeneca's Iressa from 62,010 won per tablet to 55,003 won, a civic group said it plans to call on the government to lower the prices of innovative drugs, to help ease the burden on patients.

The Health Right Network said it is now conducting a survey of hard-to-cure patients to investigate the cost and clinical effectiveness of newly inve...